Trajectories of gray and white matter volume in children at elevated risk for schizophrenia
CNS Spectrums · 2026 · 31 (1)
DOI: 10.1017/s1092852926101047 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Spectrums, online erschienen am 09.06.2026. Verfasst von Shuqing Si und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychosis Studies, King's College London, UK. Hauptthemen laut MEDLINE: White Matter, Schizophrenia, Gray Matter. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Institute for Health Research.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Longitudinal investigation of brain alterations in children putatively at risk of developing schizophrenia may identify early markers of pathophysiology associated with vulnerability for the disorder.
Methods
Children aged 9–12 years with multiple antecedents of schizophrenia (psychotic-like experiences; speech and/or motor delays; and social, emotional, and/or behavioral difficulties; ASz, n = 31), with a family history of schizophrenia/schizoaffective disorder (FHx, n = 21), and typically developing children (TD, n = 35) were recruited through community screening using questionnaires. T1-weighted structural MRI scans were obtained at baseline and after approximately 2 and 4 years of follow-up, and processed using the FreeSurfer longitudinal pipeline. Across these 3 assessment waves, total gray matter (GM) and white matter (WM) volume, and regional GM volumes in 12 regions of interest, were compared among the groups using linear mixed models.
Results
Children were aged 11.21 (±1.61) years at baseline and the average lapse-of-time between each assessment was 1.76 (±0.36) years. The ASz group exhibited consistently higher total WM volume ( b = 29.45) compared to the TD group, with no statistically significant time-related volumetric WM or GM differences in any region. The FHx group also demonstrated higher total WM volume ( b = 36.49), and time-related total and regional GM volume changes were observed; however, these effects were attenuated after correction.
Conclusion
Global and regionally specific brain abnormalities distinguished children with different risk profiles for schizophrenia relative to their typically developing peers. Follow-up is required to determine how these changes may relate to later schizophrenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychosis Studies, King's College London, UK.
- Center for AI and Data Science for Integrated Diagnostics, and Center for Biomedical Image Computing and Analytics,University of Pennsylvania, USA.
- Education & Training Division, Anna Freud Centre, UK.
- Research Department of Clinical, Educational & Health Psychology, University College London, UK.
- National Institute for Health Research (NIHR), Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, UK.
- Division of Insurance Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Sweden.
ORCID-Profile: Kristin R Laurens
Förderung
- Wellcome Trust
- National Institute for Health Research
Zitieren
APA
Si, S., Kempton, M., Hedges, E., Antoniades, M., Roberts, R. E., Cullen, A. E., & Laurens, K. R. (2026). Trajectories of gray and white matter volume in children at elevated risk for schizophrenia. CNS Spectrums, 31(1). https://doi.org/10.1017/s1092852926101047
Vancouver
Si S, Kempton M, Hedges E, Antoniades M, Roberts RE, Cullen AE, et al. Trajectories of gray and white matter volume in children at elevated risk for schizophrenia. CNS Spectrums. 2026;31(1). doi:10.1017/s1092852926101047
BibTeX
@article{Si2026,
author = {Si, Shuqing and Kempton, Matthew and Hedges, Emily and Antoniades, Mathilde and Roberts, Ruth E and Cullen, Alexis E and Laurens, Kristin R},
title = {Trajectories of gray and white matter volume in children at elevated risk for schizophrenia},
journal = {CNS Spectrums},
year = {2026},
volume = {31},
number = {1},
doi = {10.1017/s1092852926101047}
}
EUVIMED